Market revenue in 2023 | USD 173.4 million |
Market revenue in 2030 | USD 463.5 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | Hydrogels |
Fastest growing segment | Nanofiber Based Scaffolds |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Tecan Group AG, Becton Dickinson & Co, Medtronic PLC, Matricelf Ltd, Corning Inc, Avacta Group PLC, Vericel Corp, NuVasive, Allergan, ReproCELL, 3D Biotek, Xanofi, Molecular Matrix, Pelo Biotech, Azenta Life Sciences, Akron Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scaffold technology market will help companies and investors design strategic landscapes.
Hydrogels was the largest segment with a revenue share of 41.58% in 2023. Horizon Databook has segmented the Japan scaffold technology market based on hydrogels, polymeric scaffolds, micropatterned surface microplates, nanofiber based scaffolds covering the revenue growth of each sub-segment from 2018 to 2030.
Currently, Japan is considered to be the second-largest biopharmaceutical market. Consistent introduction of new products and their usage in research studies are expected to augment both demand and growth of this market over the forecast period.
For instance, the product JMJD1A was used in a research study published in May 2015. It is a cAMP-responsive scaffold that allows chromatin interactions. Some of the major players operating in this country are REPROCELL (Japan), 3D-Matrix Ltd., and Ferentis. Key players are opting for various strategic initiatives to reinforce their position in the market, which is expected to boost its revenue in the coming years.
For example, in August 2014, REPROCELL (Japan) acquired Reinnervate Ltd. and BioServe, Inc. to add stem cell culture media, 3D cell culture, iPSC-derived cells, and human tissue samples to its portfolio.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan scaffold technology market , including forecasts for subscribers. This country databook contains high-level insights into Japan scaffold technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account